Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones

Abstract

The present invention relates to extracts from Cimicifuga species and particularly from Cimicifuga racemosa , which are suited for producing a ready-formulated drug for the selective treatment and/or prophylaxis of sexual hormone-related disorders of the uro-genital tract. The extracts in accordance with the invention are moreover suited for the treatment and/or prophylaxis of post-menopausal urinary bladder infections. They are furthermore indicated for the treatment of benign and malignant prostate hyperplasies.

1 - 22 . (canceled) 
     
     
         23 . An estrogen-type organoselective medicament having at most a negligible uterotrophic effect, the medicament comprising an extract from a  Cimicifuga  species, the medicament adapted for alleviating a post-menopausally occurring urinary bladder infection when administered. 
     
     
         24 . The medicament of  claim 23  wherein the  Cimicifuga  species is selected from the group consisting of:  C. racemosa, C. foetida, C. dahurica, C. heracleifolia, C. simplex, C. japonica, C. europaea, C. acerina, C. elata , and  C. rubifolia.    
     
     
         25 . The medicament of  claim 24  wherein the  Cimicifuga  species is  C. racemosa.    
     
     
         26 . The medicament of  claim 23 , wherein the extract is produced from a  Cimicifuga  species by extraction with an organic solvent. 
     
     
         27 . The medicament of  claim 23 , wherein the extract is produced from a  Cimicifuga  species by extraction with a mixture of an organic solvent and water. 
     
     
         28 . The medicament of  claim 23 , wherein the extract is produced from a  Cimicifuga  species by extraction with supercritical CO 2 . 
     
     
         29 . A method for alleviating a sexual hormone-related post menopausal urinary bladder infection comprising the step of administering an estrogen-type organoselective medicament to alleviate the infection, the medicament comprising an extract from a  Cimicifuga  species. 
     
     
         30 . The method of  claim 29 , wherein the  Cimicifuga  species is selected from the group consisting of:  C. racemosa, C. foetida, C. dahurica, C heracleifolia, C. simplex, C. japonica, C. europaea, C. acerina, C. elata , and  C. rubifolia.    
     
     
         31 . The method of  claim 30 , wherein the  Cimicifuga  species is  C. racemosa.    
     
     
         32 . The method of  claim 29 , wherein the extract is produced from a  Cimicifuga  species by extraction with an organic solvent, such that the method alleviates the infection. 
     
     
         33 . The method of  claim 29 , wherein the extract is produced from a  Cimicifuga  species by extraction with a mixture of an organic solvent and water, such that the method alleviates the infection. 
     
     
         34 . The method of  claim 29 , wherein the extract is produced from a  Cimicifuga  species by extraction with supercritical CO 2 ,such that the method alleviates the infection.